IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

Vaccine Roundup: Merck Wipes Out

Science

January 25, 2021

Read more

Press Releases

Merck and IAVI Discontinue Development of COVID-19 Vaccine Candidate V590

January 25, 2021

Research will continue on COVID-19 vaccine platform.

Read more

Scientific Publications

HIV 1 Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity

Read more

Videos

Why An HIV Vaccine

January 22, 2021

Despite great progress in HIV prevention and in treatment using antiretroviral therapy, there are still almost 40 million people living with HIV globally. Our best long-term hope to end the HIV/AIDS pandemic is a safe, effective, preventive vaccine that can be used worldwide.

Read more

Videos

HIV Vaccine Development

January 22, 2021

An overview of the process of HIV vaccine development and the many steps that a vaccine has to pass in order to guarantee it’s safe and effective to use.

Read more

Scientific Publications

HIV 1 Entry and Prospects for Protecting against Infection

Read more

Features

IAVI at HIVR4P Virtual 2021

January 19, 2021

IAVI to participate in major HIV prevention research conference beginning January 27.

Read more

Press Releases

Researchers demonstrate protection offered by novel TB vaccine candidate in animal model

January 13, 2021

A study of MTBVAC efficacy in a macaque model of tuberculosis shows that the vaccine candidate protects against aerosol infection with Mycobacterium tuberculosis. Researchers from Europe and the U.S. demonstrate that the MTBVAC vaccine protects better than the current BCG vaccine in a model of tuberculosis in macaques and compare the immunological patterns to those…

Read more